Susanna Fischer

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 357 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin.

Samia Mankarious, M Lee, Susanna Fischer et al. · PubMed · 1988 · 247 citations

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

M. Farrington, Laura S. Grosmaire, Shigeaki Nonoyama et al. · Proceedings of the National Academy of Sciences · 1994 · 230 citations · Full text

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

Hans D. Ochs, Susanna Fischer, Ralph Wedgwood et al. · The American Journal of Medicine · 1984 · 105 citations

Primary Immunodeficiency, Treatment And Prevention, Immunodeficiencies +8

Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2–harboring clones as main relapse-driving force in childhood ALL

Maria Morak, Andishe Attarbaschi, Susanna Fischer et al. · Blood · 2012 · 56 citations · Full text